Thursday, February 5, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analysts Remain Bullish on Zscaler with Revised Price Targets

Elaine Mendonca by Elaine Mendonca
March 2, 2024
in Breaking News
0
Tech-Innovations
0
SHARES
3
VIEWS
Share on FacebookShare on Twitter

Baird analyst Shrenik Kothari remains bullish on Zscaler (NASDAQ: ZS) with an Outperform rating and a revised price target of $265, up from $255. This adjustment signifies a strong belief in the company’s future performance.
_____
In addition to Kothari’s optimistic outlook, other analysts have also expressed positive views on Zscaler. Truist Securities’ Ki Bin Kim set a price target of $260, Rosenblatt’s Catharine Trebnick at $285, and Barclays’ Saket Kalia at $259, all indicating confidence in the stock.

Zscaler Inc. (ZS) Stock Price Plummets: Factors Behind the 9.40% Drop on March 2, 2024

On March 2, 2024, Zscaler Inc. (ZS) experienced a significant drop in its stock price performance. The price of ZS shares decreased by $22.74 since the market last closed, representing a 9.40% drop. The stock closed at $219.23, but has since dropped an additional $1.03 in after-hours trading.

This sudden decline in ZS stock price may have been influenced by a variety of factors, such as market volatility, economic conditions, or company-specific news. Investors and analysts will likely be closely monitoring the situation to determine the underlying causes of this drop and assess the potential impact on ZS’s future performance.

Despite this recent setback, it’s important to note that stock prices can be volatile and subject to fluctuations in the short term. Investors should consider the long-term fundamentals of the company, its growth prospects, and overall market conditions before making any investment decisions based on short-term price movements.

As with any investment, it’s crucial for investors to conduct thorough research, stay informed about market developments, and consult with financial advisors to make well-informed decisions. While the drop in ZS stock price on March 2 may be concerning to some investors, it’s important to keep in mind that stock prices can be unpredictable and that market conditions can change rapidly.

ZS Stock Reports Strong Financial Results with 48% Revenue Increase in 2024

On March 2, 2024, ZS stock showed promising performances as the company reported strong financial results for the past year and the second quarter. According to data from CNN Money, ZS’s total revenue for the year was $1.62 billion, which marked a significant increase of 48.22% compared to the previous year. Additionally, the total revenue for the second quarter was $525.00 million, showing a 5.7% increase from the previous quarter.

In terms of net income, ZS reported a net loss of $202.34 million for the year, but this figure actually represented a 48.16% improvement from the previous year. For the second quarter, the net loss was $28.47 million, indicating a 14.97% increase from the previous quarter.

Furthermore, ZS’s earnings per share (EPS) also showed positive growth trends. The EPS for the year was -$1.40, which was a 49.6% improvement from the previous year. In the second quarter, the EPS was -$0.19, showing a 15.74% increase from the previous quarter.

Tags: ZS
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Financing and finances

Morgan Stanley Reiterates EqualWeight Rating for Best Buy Co with Increased Price Target

Investings on laptops and finances

Wells Fargo Analyst Upgrades Price Target for Chart Industries NYSE GTLS

Biotechnology Stock Market Today (1)

Annexon Inc Receives Upgrade from JP Morgan and Positive Outlook for GBS Treatment

Recommended

FITB stock news

Davenport & Co LLC Boosts Stake in Starwood Property Trust, Inc.: A Resilient REIT Positioned for Growth

3 years ago
AT&T Stock

AT&T Bets Big on Network Transformation with Massive Infrastructure Push

5 months ago
Dominion Energy Stock

Dominion Energy Faces Critical Earnings Test Amid Diverging Metrics

3 months ago
Riot Blockchain Stock

Riot Blockchain Stock: Riding the Bitcoin Mining Momentum

5 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Strategic Robotics Partnership Signals New Growth Phase for EOS Defence

NexPoint Residential Trust Sets Date for Annual and Q4 2025 Results

PC Connection Set to Report Full-Year and Fourth Quarter Earnings

Fossil Group Stock Surges Past Key Technical Threshold

NextGen Healthcare: Strategic Wins and Industry Accolades Signal Sustained Momentum

Arcus Biosciences Pivots Pipeline Strategy Following Clinical Setback

Trending

Viking Therapeutics Stock
Analysis

Viking Therapeutics: Investors Await Key Clinical Updates in Forthcoming Report

by Dieter Jaworski
February 5, 2026
0

Shares of Viking Therapeutics are trading within a consolidated range as the market anticipates significant corporate news....

Solana Stock

Solana Faces Billions in Potential Token Supply Releases

February 5, 2026
CureVac Stock

CureVac Delisted Following BioNTech Acquisition Completion

February 5, 2026
EOS Stock

Strategic Robotics Partnership Signals New Growth Phase for EOS Defence

February 5, 2026
NexPoint Residential Stock

NexPoint Residential Trust Sets Date for Annual and Q4 2025 Results

February 4, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Viking Therapeutics: Investors Await Key Clinical Updates in Forthcoming Report
  • Solana Faces Billions in Potential Token Supply Releases
  • CureVac Delisted Following BioNTech Acquisition Completion

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com